* Co-Diagnostics Inc CODX.OQ CODX.O is expected to show
a rise
in quarterly revenue when it reports results on March 14 for
the period ending December 31 2023
* The Salt Lake City Utah-based company is expected to
report a
158.7% increase in revenue to $3.625 million from $1.4 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Co-Diagnostics Inc is
for a
loss of 20 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $3.00, above its last closing price of $1.14.
This summary was machine generated March 12 at 21:10 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)